24 May 2013
Keywords: vernalis, placement, lifts, stock, uk-based, biotechnology, concern
Article | 12 May 2003
UK-based biotechnology concern Vernalis, one of only a few companies inthe sector with a drug already on the market, has ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 May 2003
5 May 2003
19 May 2003
© 2013 thepharmaletter.com